All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Pr Newswire

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

admin
Pr Newswire

MBX Biosciences to Present at the American Diabetes Association 85th Scientific...

admin
Pr Newswire

Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

admin
Pr Newswire

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual...

admin
Pr Newswire

DeepView® System highlighted at the annual British Burn Association conference

admin
People

Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations

admin
Pr Newswire

Circle’s Blockbuster IPO Signals Major Crypto Public Offering Wave, Bybit Analysis...

admin
Pr Newswire

Univar Solutions Publishes 2024 Environmental, Social and Governance (ESG) Report

admin
Pr Newswire

Altair Announces ATCx AI for Engineers 2025 Global Virtual Event

admin
Pr Newswire

RAINBOWCO Upgrades Global Brand Strategy, Strengthening GENMA’s Leadership in High-End Equipment

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...